Cancer clinical trial aims to activate immune system
A new Sanford Health clinical trial will explore a drug’s ability to activate the body’s immune system to fight head and neck cancer. Oncologist and cancer researcher Steven Powell, M.D., developed and will lead the Merck Investigator Studies Program (MISP) trial using the investigational drug pembrolizumab in combination with chemotherapy and radiation therapy for participants […]